- Home
- Publications
- Publication Search
- Publication Details
Title
Current Perspectives on 89Zr-PET Imaging
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 12, Pages 4309
Publisher
MDPI AG
Online
2020-06-18
DOI
10.3390/ijms21124309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with metastatic neuroendocrine tumours: a systematic review and meta-analysis
- (2020) Jie Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate
- (2020) Stijn JH Waaijer et al. Journal for ImmunoTherapy of Cancer
- ImmunoPET imaging to assess target engagement: Experience from 89Zr-anti-HER3 mAb (GSK2849330) in patients with solid tumors
- (2019) Catharina Willemien Menke-van der Houven van Oordt et al. JOURNAL OF NUCLEAR MEDICINE
- Digital PET/CT: a new intriguing chance for clinical nuclear medicine and personalized molecular imaging
- (2019) Orazio Schillaci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer
- (2019) M. Ankersmit et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Thiol-Reactive Bifunctional Chelators for the Creation of Site-Selectively Modified Radioimmunoconjugates with Improved Stability
- (2018) Pierre Adumeau et al. BIOCONJUGATE CHEMISTRY
- Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer
- (2018) Farrokh Dehdashti et al. BREAST CANCER RESEARCH AND TREATMENT
- HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging
- (2018) Carlos D. Martins et al. CLINICAL CANCER RESEARCH
- Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
- (2018) Chloe Peach et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody
- (2018) Masahide Matsuda et al. JOURNAL OF NEURO-ONCOLOGY
- Positron emission tomography of adoptively transferred chimeric antigen receptor T cells with Zirconium-89 oxine
- (2018) Michael Ryan Weist et al. JOURNAL OF NUCLEAR MEDICINE
- Recent Advances in Zirconium-89 Chelator Development
- (2018) Nikunj Bhatt et al. MOLECULES
- 89 Zr for antibody labeling and in vivo studies – A comparison between liquid and solid target production
- (2018) Gemma M. Dias et al. NUCLEAR MEDICINE AND BIOLOGY
- Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors
- (2018) Denis R. Beckford Vera et al. PLoS One
- Hepatocyte spheroids as an alternative to single cells for transplantation after ex vivo gene therapy in mice and pig models
- (2018) Clara T. Nicolas et al. SURGERY
- 89Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I
- (2018) Rufeal Chekol et al. Oncotarget
- Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe
- (2018) Derrek A. Heuveling et al. EJNMMI Research
- PSMA Theranostics: Current Status and Future Directions
- (2018) Kambiz Rahbar et al. Molecular Imaging
- The application of CAR-T cell therapy in hematological malignancies: Advantages and challenges
- (2018) Zijun Zhao et al. Acta Pharmaceutica Sinica B
- 89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
- (2018) Frederike Bensch et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Affibody-based PET imaging to guide EGFR-targeted cancer therapy in head and neck squamous cell cancer models
- (2018) Thomas A. Burley et al. JOURNAL OF NUCLEAR MEDICINE
- Feasibility of Vascular Endothelial Growth Factor Imaging in Human Atherosclerotic Plaque Using 89 Zr-Bevacizumab Positron Emission Tomography
- (2018) Reza Golestani et al. Molecular Imaging
- Phase I/IIa PET imaging study with 89zirconium labeled anti-PSMA minibody for urological malignancies
- (2018) Akira Joraku et al. ANNALS OF NUCLEAR MEDICINE
- An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions
- (2018) Leila Farzin et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
- (2018) Frederike Bensch et al. NATURE MEDICINE
- EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
- (2018) Francisco Sanchez-Vega et al. Cancer Discovery
- 89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer
- (2017) Christopher G. England et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
- (2017) Gary A. Ulaner et al. JOURNAL OF NUCLEAR MEDICINE
- 89 Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma
- (2017) Suzanne C. van Es et al. JOURNAL OF NUCLEAR MEDICINE
- Multiregional Tumor Drug-Uptake Imaging by PET and Microvascular Morphology in End-Stage Diffuse Intrinsic Pontine Glioma
- (2017) Sophie E.M. Veldhuijzen van Zanten et al. JOURNAL OF NUCLEAR MEDICINE
- Long–Half-Life89Zr-Labeled Radiotracers Can Guide Percutaneous Biopsy Within the PET/CT Suite Without Reinjection of Radiotracer
- (2017) Francois H. Cornelis et al. JOURNAL OF NUCLEAR MEDICINE
- Pharmacokinetics, Biodistribution, and Radiation Dosimetry for89Zr-Trastuzumab in Patients with Esophagogastric Cancer
- (2017) Joseph A. O'Donoghue et al. JOURNAL OF NUCLEAR MEDICINE
- Multifunctional Desferrichrome Analogues as Versatile 89Zr(IV) Chelators for ImmunoPET Probe Development
- (2017) Casey J. Adams et al. MOLECULAR PHARMACEUTICS
- Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
- (2017) Yvonne W. S. Jauw et al. PLoS One
- In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PET
- (2017) Nahid Yusufi et al. Theranostics
- Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic Therapy
- (2016) Anyanee Kamkaew et al. ACS Nano
- 89Zr-rituximab PET/CT to detect neurolymphomatosis
- (2016) Antoinette de Jong et al. AMERICAN JOURNAL OF HEMATOLOGY
- Spot-welding solid targets for high current cyclotron irradiation
- (2016) Paul A. Ellison et al. APPLIED RADIATION AND ISOTOPES
- HDL mimetic CER-001 targets atherosclerotic plaques in patients
- (2016) Kang He Zheng et al. ATHEROSCLEROSIS
- 89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease
- (2016) S. F. Oosting et al. JOURNAL OF NUCLEAR MEDICINE
- First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
- (2016) N. Pandit-Taskar et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular Drug Imaging:89Zr-Bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma
- (2016) Marc H. Jansen et al. JOURNAL OF NUCLEAR MEDICINE
- Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
- (2016) G. A. Ulaner et al. JOURNAL OF NUCLEAR MEDICINE
- Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy
- (2016) B. M. Larimer et al. JOURNAL OF NUCLEAR MEDICINE
- [89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
- (2016) Richard Laforest et al. MOLECULAR IMAGING AND BIOLOGY
- Improved production and processing of 89 Zr using a solution target
- (2016) Mukesh K. Pandey et al. NUCLEAR MEDICINE AND BIOLOGY
- Tracking and Therapeutic Value of Human Adipose Tissue–derived Mesenchymal Stem Cell Transplantation in Reducing Venous Neointimal Hyperplasia Associated with Arteriovenous Fistula
- (2016) Binxia Yang et al. RADIOLOGY
- In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models
- (2016) Carlos Pérez-Medina et al. JACC-Cardiovascular Imaging
- Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach
- (2016) Aniek J.G. Even et al. Oncotarget
- Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab
- (2016) Martin Pool et al. Oncotarget
- Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling
- (2016) Edward K. Fung et al. EJNMMI Research
- Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
- (2015) G. Gebhart et al. ANNALS OF ONCOLOGY
- Tumor-Infiltrating Lymphocyte Therapy
- (2015) Laszlo G. Radvanyi CANCER JOURNAL
- A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
- (2015) N. Pandit-Taskar et al. CLINICAL CANCER RESEARCH
- PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of 89Zr-Cetuximab
- (2015) N. E. Makris et al. JOURNAL OF NUCLEAR MEDICINE
- PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles
- (2015) C. Perez-Medina et al. JOURNAL OF NUCLEAR MEDICINE
- Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies
- (2015) R. Tavare et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-cetuximab PET imaging in patients with advanced colorectal cancer
- (2015) Catherina Willemien Menke-van der Houven et al. Oncotarget
- The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies
- (2015) Brian M. Zeglis et al. Jove-Journal of Visualized Experiments
- Novel 89Zr cell labeling approach for PET-based cell trafficking studies
- (2015) Aditya Bansal et al. EJNMMI Research
- Heterogeneity of intratumoral 111In-ibritumomab tiuxetan and 18F-FDG distribution in association with therapeutic response in radioimmunotherapy for B-cell non-Hodgkin’s lymphoma
- (2015) Kohei Hanaoka et al. EJNMMI Research
- A solid target system with remote handling of irradiated targets for PET cyclotrons
- (2014) J. Siikanen et al. APPLIED RADIATION AND ISOTOPES
- Molecular Pathways: HER3 Targeted Therapy
- (2014) K. Gala et al. CLINICAL CANCER RESEARCH
- 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
- (2014) Neeta Pandit-Taskar et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment
- (2014) S. F. Oosting et al. JOURNAL OF NUCLEAR MEDICINE
- Noninvasive Imaging of PSMA in Prostate Tumors with 89Zr-Labeled huJ591 Engineered Antibody Fragments: The Faster Alternatives
- (2014) Nerissa Therese Viola-Villegas et al. MOLECULAR PHARMACEUTICS
- Evaluation of 89Zr-pertuzumab in Breast Cancer Xenografts
- (2014) Bernadette V. Marquez et al. MOLECULAR PHARMACEUTICS
- ImmunoPET Imaging of Renal Cell Carcinoma with 124I- and 89Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice
- (2013) Alexander B. Stillebroer et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Polymeric Nanoparticle PET/MR Imaging Allows Macrophage Detection in Atherosclerotic Plaques
- (2013) Maulik D. Majmudar et al. CIRCULATION RESEARCH
- 89Zr-Bevacizumab PET Imaging in Primary Breast Cancer
- (2013) S. B. M. Gaykema et al. JOURNAL OF NUCLEAR MEDICINE
- Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET
- (2013) Y. Y. Janjigian et al. JOURNAL OF NUCLEAR MEDICINE
- Pilot Study on the Feasibility of PET/CT Lymphoscintigraphy with 89Zr-Nanocolloidal Albumin for Sentinel Node Identification in Oral Cancer Patients
- (2013) D. A. Heuveling et al. JOURNAL OF NUCLEAR MEDICINE
- A Prospective Pilot Study of 89Zr-J591/Prostate Specific Membrane Antigen Positron Emission Tomography in Men with Localized Prostate Cancer Undergoing Radical Prostatectomy
- (2013) Joseph R. Osborne et al. JOURNAL OF UROLOGY
- Preclinical evaluation of89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys
- (2013) Danielle J Vugts et al. mAbs
- Mapping biological behaviors by application of longer-lived positron emitting radionuclides
- (2012) Yang Zhou et al. ADVANCED DRUG DELIVERY REVIEWS
- Measurement of Tumor VEGF-A Levels with 89Zr-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft Model
- (2012) A. R. M. van der Bilt et al. CLINICAL CANCER RESEARCH
- Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89Zr-ibritumomab tiuxetan and PET
- (2012) Saiyada N. F. Rizvi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET and MRI of Metastatic Peritoneal and Pulmonary Colorectal Cancer in Mice with Human Epidermal Growth Factor Receptor 1-Targeted 89Zr-Labeled Panitumumab
- (2012) T. K. Nayak et al. JOURNAL OF NUCLEAR MEDICINE
- Lapatinib and 17AAG Reduce 89Zr-Trastuzumab-F(ab′)2 Uptake in SKBR3 Tumor Xenografts
- (2012) Thijs H. Oude Munnink et al. MOLECULAR PHARMACEUTICS
- 89Zr-Labeled Dextran Nanoparticles Allow in Vivo Macrophage Imaging
- (2011) Edmund J. Keliher et al. BIOCONJUGATE CHEMISTRY
- Targeting the Internal Epitope of Prostate-Specific Membrane Antigen with 89Zr-7E11 Immuno-PET
- (2011) A. Ruggiero et al. JOURNAL OF NUCLEAR MEDICINE
- 89Zr-Nanocolloidal Albumin-Based PET/CT Lymphoscintigraphy for Sentinel Node Detection in Head and Neck Cancer: Preclinical Results
- (2011) D. A. Heuveling et al. JOURNAL OF NUCLEAR MEDICINE
- In vivo biodistribution and accumulation of 89Zr in mice
- (2011) Diane S. Abou et al. NUCLEAR MEDICINE AND BIOLOGY
- A Pretherapy Biodistribution and Dosimetry Study of Indium-111-Radiolabeled Trastuzumab in Patients with Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer
- (2010) Jeffrey Y.C. Wong et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment
- (2010) W. B. Nagengast et al. CANCER RESEARCH
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- In vivo biodistribution of stem cells using molecular nuclear medicine imaging
- (2010) Mick M. Welling et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cerenkov Luminescence Imaging of Medical Isotopes
- (2010) A. Ruggiero et al. JOURNAL OF NUCLEAR MEDICINE
- Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab
- (2010) Jason P. Holland et al. PLoS One
- CD20-Targeted Therapy: The Next Generation of Antibodies
- (2010) Tom van Meerten et al. SEMINARS IN HEMATOLOGY
- Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
- (2009) E. C.F. Dijkers et al. JOURNAL OF NUCLEAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started